Corrigendum to “HQS-3, a newly synthesized flavonoid, possesses potent anti-tumor effect in vivo and in vitro” (HQS-3, a newly synthesized flavonoid, possesses potent anti-tumor effect in vivo and in vitro (2013) 49(4) (649–658), (S0928098713001437), (10.1016/j.ejps.2013.04.016));HQS-3, a newly synthesized flavonoid, possesses potent anti-tumor effect in vivo and in vitro

European Journal of Pharmaceutical Sciences

Volumn 49, Issue 4, 2013, Pages 649-658

  Zhou, Yuxin ^a   Lu, Na ^a   Zhang, Haiwei ^a   Wei, Libin ^a   Tao, Lei ^a   Dai, Qinsheng ^a   Zhao, Li ^a   Lin, Biqi ^a   Ding, Qilong ^a   Guo, Qinglong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Anti tumor; Apoptosis; Bax Bcl 2; HQS 3; Mitochondrial mediated; ROS

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; CASPASE 3; CASPASE 9; FLAVONOID; HQS 3; LIPOCORTIN 5; MANGANESE SUPEROXIDE DISMUTASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BODY WEIGHT; CANCER INHIBITION; CELL STRAIN HEPG2; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG SYNTHESIS; ENZYME ACTIVITY; FEMALE; HEPATOMA CELL; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NEOPLASM; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

EID: 84879492665     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2019.105074     Document Type: Erratum

References (44)

1. Aiyegoro, O.A., Okoh, A.I., 2009. Phytochemical screening and polyphenolic antioxidant activity of aqueous crude leaf extract of Helichrysum pedunculatum. Int. J. Mol. Sci. 10, 4990-5001.
2. Antonsson, B., Conti, F., Ciavatta, A., Montessuit, S., Lewis, S., Martinou, I., Bernasconi, L., Bernard, A., Mermod, J.J., Mazzei, G., Maundrell, K., Gambale, F., Sadoul, R., Martinou, J.C., 1997. Inhibition of Bax channel-forming activity by Bcl-2. Science 277, 370-372. (Pubitemid 27450709)
3. Benz, C.C., Yau, C., 2008. Ageing, oxidative stress and cancer: paradigms in parallax. Nat. Rev. Cancer 8, 875-879.
4. Berens, H.M., Tyler, K.L., 2011. The proapoptotic Bcl-2 protein Bax plays an important role in the pathogenesis of reovirus encephalitis. J. Virol. 85, 3858-3871.
5. Bobyleva, V., Pazienza, T.L., Maseroli, R., Tomasi, A., Salvioli, S., Cossarizza, A., Franceschi, C., Skulachev, V.P., 1998. Decrease in mitochondrial energy coupling by thyroid hormones: a physiological effect rather than a pathological hyperthyroidism consequence. FEBS Lett. 430, 409-413. (Pubitemid 28337955)
6. Bruix, J., Sherman, M., Llovet, J.M., Beaugrand, M., Lencioni, R., Burroughs, A.K., Christensen, E., Pagliaro, L., Colombo, M., Rodes, J., 2001. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J. Hepatol. 35, 421-430. (Pubitemid 32844200)
7. Chen, C.H., Huang, T.S., Wong, C.H., Hong, C.L., Tsai, Y.H., Liang, C.C., Lu, F.J., Chang, W.H., 2009. Synergistic anti-cancer effect of baicalein and silymarin on human hepatoma HepG2 Cells. Food Chem. Toxicol. 47, 638-644.
8. DeRosier, L.C., Buchsbaum, D.J., Oliver, P.G., Huang, Z.Q., Sellers, J.C., Grizzle, W.E., Wang, W., Zhou, T., Zinn, K.R., Long, J.W., Vickers, S.M., 2007. Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer. Clin. Cancer Res. 13, 5535s-5543s. (Pubitemid 47510384)
9. Elchuri, S., Oberley, T.D., Qi, W., Eisenstein, R.S., Jackson Roberts, L., Van Remmen, H., Epstein, C.J., Huang, T.T., 2005. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 24, 367-380. (Pubitemid 40188585)
10. Fazal, F., Gu, L., Ihnatovych, I., Han, Y., Hu, W., Antic, N., Carreira, F., Blomquist, J.F., Hope, T.J., Ucker, D.S., de Lanerolle, P., 2005. Inhibiting myosin light chain kinase induces apoptosis in vitro and in vivo. Mol. Cell Biol. 25, 6259-6266. (Pubitemid 40946573)
11. Galluzzi, L., Joza, N., Tasdemir, E., Maiuri, M.C., Hengartner, M., Abrams, J.M., Tavernarakis, N., Penninger, J., Madeo, F., Kroemer, G., 2008. No death without life: vital functions of apoptotic effectors. Cell. Death Differ. 15, 1113-1123. (Pubitemid 351850963)
12. Han, K.H., Park, J.Y., 2010. Systemic treatment in advanced/metastatic hepatocellular carcinoma in the era of targeted therapy. J. Gastroenterol. Hepatol. 25, 1023-1025.
13. Heimlich, G., McKinnon, A.D., Bernardo, K., Brdiczka, D., Reed, J.C., Kain, R., Kronke, M., Jurgensmeier, J.M., 2004. Bax-induced cytochrome c release from mitochondria depends on alpha-helices-5 and -6. Biochem. J. 378, 247-255. (Pubitemid 38299564)
14. Hetz, C., 2010. BCL-2 protein family. Essential regulators of cell death. Preface. Adv. Exp. Med. Biol. 687, vii-viii.
15. Hu, Y., Rosen, D.G., Zhou, Y., Feng, L., Yang, G., Liu, J., Huang, P., 2005. Mitochondrial manganese-superoxide dismutase expression in ovarian cancer: role in cell proliferation and response to oxidative stress. J. Biol. Chem. 280, 39485-39492. (Pubitemid 41713906)
16. Jalving, M., de Jong, S., Koornstra, J.J., Boersma-van Ek, W., Zwart, N., Wesseling, J., de Vries, E.G., Kleibeuker, J.H., 2006. TRAIL induces apoptosis in human colorectal adenoma cell lines and human colorectal adenomas. Clin. Cancer Res. 12, 4350-4356.
17. Kandaswami, C., Lee, L.T., Lee, P.P., Hwang, J.J., Ke, F.C., Huang, Y.T., Lee, M.T., 2005. The antitumor activities of flavonoids. In Vivo 19, 895-909.
18. Kawanishi, S., Hiraku, Y., Pinlaor, S., Ma, N., 2006. Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol. Chem. 387, 365-372.
19. Kerr, J.F., Wyllie, A.H., Currie, A.R., 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257.
20. Li, H.N., Nie, F.F., Liu, W., Dai, Q.S., Lu, N., Qi, Q., Li, Z.Y., You, Q.D., Guo, Q.L., 2009. Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo. Toxicology 257, 80-85.
21. Li, Z., Zhao, J., Li, Q., Yang, W., Song, Q., Li, W., Liu, J., 2010. KLF4 promotes hydrogenperoxide-induced apoptosis of chronic myeloid leukemia cells involving the bcl-2/bax pathway. Cell Stress Chaperon. 15, 905-912.
22. Liu, T., Hannafon, B., Gill, L., Kelly, W., Benbrook, D., 2007. Flex-Hets differentially induce apoptosis in cancer over normal cells by directly targeting mitochondria. Mol. Cancer Ther. 6, 1814-1822. (Pubitemid 46954058)
23. Liu, H.L., Jiang, W.B., Xie, M.X., 2010. Flavonoids: recent advances as anticancer drugs. Recent Pat Anticancer Drug Discov. 5, 152-164.
24. Murawaki, Y., Tsuchiya, H., Kanbe, T., Harada, K., Yashima, K., Nozaka, K., Tanida, O., Kohno, M., Mukoyama, T., Nishimuki, E., Kojo, H., Matsura, T., Takahashi, K., Osaki, M., Ito, H., Yodoi, J., Shiota, G., 2008. Aberrant expression of selenoproteins in the progression of colorectal cancer. Cancer Lett. 259, 218-230. (Pubitemid 350258671)
25. Nijveldt, R.J., van Nood, E., van Hoorn, D.E., Boelens, P.G., van Norren, K., van Leeuwen, P.A., 2001. Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 74, 418-425. (Pubitemid 32880250)
26. Nirmalan, N.J., Harnden, P., Selby, P.J., Banks, R.E., 2009. Development and validation of a novel protein extraction methodology for quantitation of protein expression in formalin-fixed paraffin-embedded tissues using western blotting. J. Pathol. 217, 497-506.
27. Pettersson, F., Dalgleish, A.G., Bissonnette, R.P., Colston, K.W., 2002. Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/Bax. Br. J. Cancer 87, 555-561.
28. Pick, A., Muller, H., Mayer, R., Haenisch, B., Pajeva, I.K., Weigt, M., Bonisch, H., Muller, C.E., Wiese, M., 2011. Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP). Bioorg. Med. Chem. 19, 2090-2102.
29. Qiang, L., Yang, Y., You, Q.D., Ma, Y.J., Yang, L., Nie, F.F., Gu, H.Y., Zhao, L., Lu, N., Qi, Q., Liu, W., Wang, X.T., Guo, Q.L., 2008. Inhibition of glioblastoma growth and angiogenesis by gambogic acid: an in vitro and in vivo study. Biochem. Pharmacol. 75, 1083-1092.
30. Reed, J.C., 1997. Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Semin. Hematol. 34, 9-19. (Pubitemid 28032415)
31. Reed, J.C., 2000. Mechanisms of apoptosis. Am. J. Pathol. 157, 1415-1430.
32. Shi, Y., Sahu, R.P., Srivastava, S.K., 2008. Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis. BMC Cancer 8, 294.
33. Suh, Y., Afaq, F., Johnson, J.J., Mukhtar, H., 2009. A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NFkappaB-signaling pathways. Carcinogenesis 30, 300-307.
34. Sun, S.Y., Hail Jr., N., Lotan, R., 2004. Apoptosis as a novel target for cancer chemoprevention. J. Natl. Cancer Inst. 96, 662-672. (Pubitemid 38660229)
35. Trachootham, D., Alexandre, J., Huang, P., 2009. Targeting cancer cells by ROSmediated mechanisms: a radical therapeutic approach? Nat. Rev. 8, 579-591.
36. Wang, W., Guo, Q.L., You, Q.D., Zhang, K., Yang, Y., Yu, J., Liu, W., Zhao, L., Gu, H.Y., Hu, Y., Tan, Z., Wang, X.T., 2006. The anticancer activities of wogonin in murine sarcoma S180 both in vitro and in vivo. Biol. Pharm. Bull. 29, 1132-1137. (Pubitemid 43845471)
37. Wang, M., Zhang, L., Han, X., Yang, J., Qian, J., Hong, S., Samaniego, F., Romaguera, J., Yi, Q., 2007. Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways. Blood 109, 5455-5462. (Pubitemid 46890569)
38. Wang, X., Zhang, J., Xu, T., 2008. Thioredoxin reductase inactivation as a pivotal mechanism of ifosfamide in cancer therapy. Eur. J. Pharmacol. 579, 66-73.
39. Wang, B., Feng, Y., Song, X., Liu, Q., Ning, Y., Ou, X., Yang, J., Zhang, X., Wen, F., 2009. Involvement of ERK, Bcl-2 family and caspase 3 in recombinant human activin A - induced apoptosis in A549. Toxicology 258, 176-183.
40. Wang, P., Zhen, H., Jiang, X., Zhang, W., Cheng, X., Guo, G., Mao, X., Zhang, X., 2010. Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax. BMC Cancer 10, 661.
41. Yang, X.R., Wang, Y.Y., La, K.K., Peng, L., Song, X.H., Shi, X.G., Zhu, X.F., Leung, P.C., Ko, C.H., Ye, C.X., 2012. Inhibitory effects of cocoa tea (Camellia ptilophylla) in human hepatocellular carcinoma HepG2 in vitro and in vivo through apoptosis. J. Nutr. Biochem. 23, 1051-1057.
42. Yin, A., Jiang, Y., Zhang, X., Luo, H., 2010. Overexpression of FADD enhances 5- fluorouracil-induced apoptosis in colorectal adenocarcinoma cells. Med. Oncol. 27, 397-405.
43. Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., Susin, S.A., Petit, P.X., Mignotte, B., Kroemer, G., 1995. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182, 367-377.
44. Zhang, Z.M., Guo, J.X., Zhang, Z.C., Jiang, N., Zhang, Z.Y., Pan, L.J., 2011. Therapeutic options for intermediate-advanced hepatocellular carcinoma. World J. Gastroenterol. 17, 1685-1689.